Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results.
Jeffrey A CohenNadia TenenbaumJeffrey A CohenYing ZhangLudwig KapposPublished in: Therapeutic advances in neurological disorders (2019)
ClinicalTrials.gov identifier: NCT01201356.